| Being a biopharma executive has its perks. The pay can vary, but there’s still the compensation that falls under the “other” tab: company cars, home security upgrades—and global access to a private jet. Last year, the top company leaders saw flight benefits worth as much as a sky-high $1.5 million. A FiercePharma special report details the top 10 jet-setting executives of 2018, plus a few honorable mentions. And with big personnel moves this week—including a slew of positions to fill at Gilead, and a potential new chairman for GSK—we’ll see how that list of frequent flyers may change over the next year. | |
|
Featured Story | | | Thursday, July 18, 2019 Being a top biopharma executive does have its perks—not the least of which is use of the company jet. Who topped 2018’s frequent flyer list? |
|
|
Top Stories Of The Week Monday, July 15, 2019 Boehringer signed a deal to buy out a small, private immuno-oncology player this morning, and AbbVie’s been at it, too, inking a deal to snap up Mavupharma. Monday, July 15, 2019 GlaxoSmithKline is about to name a new chairman to help guide the expected split-up between its consumer health and pharma businesses. Jonathan Symonds, formerly CFO at Novartis and AstraZeneca, boasts plenty of biopharma experience. Monday, July 15, 2019 German pharma Boehringer Ingelheim is putting a few hundred million euros on the table to snap up Swiss cancer biotech Amal Therapeutics. Wednesday, July 17, 2019 New Gilead CEO Daniel O’Day has already replaced some key leaders at the company, but he’s not stopping there with the executive overhaul. Wednesday, the Big Biotech said it would bid farewell to Gregg Alton, its chief patient officer, and Katie Watson, its EVP of human resources. Wednesday, July 17, 2019 Gilead Chief Scientific Officer and R&D chief John McHutchison, M.D., is leaving one year after he took over from the company's longtime R&D lead Norbert Bischofberger, Ph.D. Tuesday, July 16, 2019 So far, Gilead’s Kite Pharma has been buying the viral vector starting material for its CAR-T treatment Yescarta from contractors. But with an expanding pipeline of cell therapies, the company says it is time to be able to produce its own. Monday, July 15, 2019 GE Healthcare has recalled two of its infant warmers—bedlike hospital devices designed to radiate heat and track the health of newborns—due to side panels and latches that may crack, break or open, allowing infants to fall. Wednesday, July 17, 2019 FDA investigators, particularly in India, have learned it is best to look beyond the production floor, clean rooms and quality control labs when doing inspections. They look around shredders, in trash cans and even barrels in factory scrap yards. Wednesday, July 17, 2019 Researchers at Boston Children’s Hospital have created a gene therapy technique that they say might work not just in an inherited form of heart arrhythmia, but also in more common cardiac diseases marked by an irregular heartbeat. Friday, July 12, 2019 They say a picture’s worth a thousand words, and Sanofi and Regeneron are using that exchange rate to their advantage with Libtayo. The teammates have a unique FDA approval to show before-and-after pictures of patients. Resources Sponsored by: Cambrex The highest number of NCEs approved by the FDA…the fastest growing small molecule clinical pipeline reported in 20 years…these are exciting times for our industry. Sponsored by: Reprints Desk, Inc. Cut your research time in half - with an easy-to-use app for scientists that combines full-featured reference management with integrated search and on-demand document delivery. Sponsored by: Almac Group Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials Sponsored by: PwC How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce? Sponsored by: United Cargo and SAVSU Technologies The combination of SAVSU technology with United Airlines’ global network has made it easier than ever to bring cell and gene therapies to destinations beyond major markets. Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Patheon, by Thermo Fisher Scientific When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need. Learn more here. Sponsored by: Veradigm Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies. Sponsored by: Patheon, by Thermo Fisher Scientific Anticipate challenges in formulation early. Sponsored by: Veradigm Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. |
